As discussed earlier, CXCL9 enables migration of more circulating TM cells to sites of infection, enhancing the activation of local DCs and NK cells and the establishment of an IFNγ-driven antiviral state providing broad protective immunity against unrelated microbial pathogens. The gene discussed is CXCL9; the disease is infection.